4-氯-2-(甲基磺酰基)苯甲酸 | 142994-03-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-氯-2-(甲基磺酰基)苯甲酸
• 中文别名: 4-氯-2-甲基磺酰苯甲酸
• 英文名称: 4-chloro-2-(methylsulphonyl)benzoic acid
• 英文别名: 2-methylsulfonyl-4-chlorobenzoic acid；4-chloro-2-(methylsulfonyl)benzoic acid；4-chloro-2-methylsulphonylbenzoic acid；4-chloro-2-methylsulfonylbenzoic acid
• CAS: 142994-03-4
• 化学式: C₈H₇ClO₄S
• 分子量: 234.66
• InChiKey: VACSKKVZIVNUDP-UHFFFAOYSA-N

物化性质

• 熔点：
  194-196°C

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  79.8
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 海关编码：
  2916399090

反应信息

• 作为反应物：
  描述：

  4-氯-2-(甲基磺酰基)苯甲酸 在 氯化亚砜 作用下， 以 甲苯 为溶剂， 反应 4.0h， 生成 2-methylsulfonyl-4-chlorobenzoyl chloride
  参考文献：
  名称：

  一种吡唑羧酸酯类化合物及其应用

  摘要：

  本发明公开一种吡唑羧酸酯类化合物及其应用，所述化合物如通式(I)所示：Q为如下基团：Q1、Q2或Q3通式I中各取代基定义见说明书。本发明通式I化合物具有优异的除草活性，可用于防治农业杂草。

  公开号：

  CN113387942A

文献信息

• DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS
  申请人：Hipskind Philip Arthur

  公开号：US20100324048A1

  公开（公告）日：2010-12-23

  The present invention provides novel 1,4-disubstituted phthalazine hedgehog pathway antagonists useful in the treatment of cancer.

  本发明提供了一种新型的1,4-二取代邻苯二酮刺猬途径拮抗剂，可用于治疗癌症。
• [EN] DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS<br/>[FR] ANTAGONISTES PHTALAZINE DISUBSTITUÉE DE LA VOIE HEDGEHOG
  申请人：LILLY CO ELI

  公开号：WO2010147917A1

  公开（公告）日：2010-12-23

  The present invention provides novel 1,4-disubstituted phthalazine of formula (I ) hedgehog pathway antagonists useful in the treatment of cancer.

  本发明提供了一种新型的1,4-二取代邻苯二酮(I)的刺猬通路拮抗剂，可用于癌症治疗。
• Disubstituted phthalazine hedgehog pathway antagonists
  申请人：Eli Lilly and Company

  公开号：US08273742B2

  公开（公告）日：2012-09-25

  The present invention provides novel 1,4-disubstituted phthalazine hedgehog pathway antagonists useful in the treatment of cancer.

  本发明提供了新型的1,4-二取代邻苯二酮刺猬途径拮抗剂，可用于治疗癌症。
• ARYL CARBOXAMIDE DERIVATIVES AS TTX-S BLOCKERS
  申请人：Yamagishi Tatsuya

  公开号：US20120232052A1

  公开（公告）日：2012-09-13

  The present invention relates to aryl carboxamide derivatives of formula (I), wherein Ar 1 is phenyl; Ar 2 is aryl; n is 1-4; X is —O—, —S—, —SO— or —SO 2 —, a prodrug thereof or a pharmaceutically acceptable salt thereof, which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of such disorders and diseases as pain in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases as pain in which voltage gated sodium channels are involved.

  本发明涉及公式（I）的芳基羧酰胺衍生物，其中Ar1是苯基；Ar2是芳基；n为1-4；X为—O—、—S—、—SO—或—SO2—，其前体药物或其药学上可接受的盐，具有阻断电压门控钠通道如TTX-S通道的活性，并在治疗或预防涉及电压门控钠通道的疾病和疾病，如疼痛方面中有用。本发明还涉及包含这些化合物的制药组合物以及这些化合物和组合物在预防或治疗涉及电压门控钠通道的疾病和疾病，如疼痛方面的使用。
• SAR and X-ray structures of enantiopure 1,2-cis-(1R,2S)-cyclopentyldiamine and cyclohexyldiamine derivatives as inhibitors of coagulation Factor Xa
  作者：Jennifer X. Qiao、Chong-Hwan Chang、Daniel L. Cheney、Paul E. Morin、Gren Z. Wang、Sarah R. King、Tammy C. Wang、Alan R. Rendina、Joseph M. Luettgen、Robert M. Knabb、Ruth R. Wexler、Patrick Y.S. Lam

  DOI：10.1016/j.bmcl.2007.06.029

  日期：2007.8

  In the search of Factor Xa (FXa) inhibitors structurally different from the pyrazole-based series, we identified a viable series of enantiopure cis-(1R,2S)-cycloalkyldiamine derivatives as potent and selective inhibitors of FXa. Among them, cyclohexyldiamide 7 and cyclopentyldiamide 9 were the most potent neutral compounds, and had good anticoagulant activity comparable to the pyrazole-based analogs. Crystal structures of 7-FXa and 9-FXa illustrate binding similarities and differences between the five-and the six-membered core systems, and provide rationales for the observed SAR of PI and linker moieties. (c) 2007 Elsevier Ltd. All rights reserved.